Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin sensitisation: Non sensitising

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
April - May 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes
Type of study:
mouse local lymph node assay (LLNA)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: EPFS 201
- Expiration date of the lot/batch: 2005-06-30
Species:
mouse
Strain:
CBA/Ca
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelman GmbH, Borchen, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: ca 8 weeks
- Weight at study initiation: 18 - 22 g
- Housing: Individually caged
- Diet (e.g. ad libitum): Commercial rodent diet (Altromin), ad libitum
- Water (e.g. ad libitum): Municipal supply, ad libitum
- Acclimation period: 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): average 22 deg C
- Humidity (%): average 46.7%
- Photoperiod (hrs dark / hrs light): 12 / 12
- IN-LIFE DATES: From: 2004-04-27 To: 2004-05-04
Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
25, 50 and 100%
No. of animals per dose:
5
Details on study design:
PRE-SCREEN TESTS:
- Irritation: no
- Systemic toxicity: no
- Ear thickness measurements: within normal range

MAIN STUDY

ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: allocated by random assigment
- Criteria used to consider a positive response: 3 fold or greater increase in stimulation index

TREATMENT PREPARATION AND ADMINISTRATION:
- as per OECD methodology
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Positive control results:
25% HCA resulted in a SI of 5.8
Parameter:
SI
Value:
0.7
Test group / Remarks:
Low dose (25%)
Parameter:
SI
Value:
0.5
Test group / Remarks:
Mid dose (50%)
Parameter:
SI
Value:
0.5
Test group / Remarks:
High dose (100%)
Interpretation of results:
GHS criteria not met
Conclusions:
The local lymph node assay (LLNA) indicates that the substance is not a skin sensitiser.
Executive summary:

Potential dermal sensitisation has been investigated in-vivo using the local lymph node assay (LLNA). There was no indication from the resultant stimulation indices that the substance acts as a sensitiser.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Justification for classification or non-classification

Based on the results of the available data the substance does not require to be classified and labelled according to Regulation 1272/2008/EC (CLP) or Directive 67/548/EEC (DSD).